BindingDB logo
myBDB logout

null

SMILES: CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2cnc(s2)-c2ccccc2)n1

InChI Key: InChIKey=IRGBHMIQDXZZDP-BZSJEYESSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 146320   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Isocitrate dehydrogenase [NADP] cytoplasmic


(Homo sapiens (Human))
BDBM146320
PNG
(US8957068, 431 | US8957068, 432)
Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2cnc(s2)-c2ccccc2)n1 |r,w:15.16|
Show InChI InChI=1S/C21H23N5O2S/c1-13(2)16-12-28-21(27)26(16)18-9-10-22-20(25-18)24-14(3)17-11-23-19(29-17)15-7-5-4-6-8-15/h4-11,13-14,16H,12H2,1-3H3,(H,22,24,25)/t14?,16-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 568n/an/an/an/a7.425



Novartis AG

US Patent


Assay Description
Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a produc...


US Patent US8957068 (2015)


BindingDB Entry DOI: 10.7270/Q2TD9W28
More data for this
Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic


(Homo sapiens (Human))
BDBM146320
PNG
(US8957068, 431 | US8957068, 432)
Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2cnc(s2)-c2ccccc2)n1 |r,w:15.16|
Show InChI InChI=1S/C21H23N5O2S/c1-13(2)16-12-28-21(27)26(16)18-9-10-22-20(25-18)24-14(3)17-11-23-19(29-17)15-7-5-4-6-8-15/h4-11,13-14,16H,12H2,1-3H3,(H,22,24,25)/t14?,16-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 44.8n/an/an/an/a7.525



Novartis AG

US Patent


Assay Description
The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...


US Patent US8957068 (2015)


BindingDB Entry DOI: 10.7270/Q2TD9W28
More data for this
Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic


(Homo sapiens (Human))
BDBM146320
PNG
(US8957068, 431 | US8957068, 432)
Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2cnc(s2)-c2ccccc2)n1 |r,w:15.16|
Show InChI InChI=1S/C21H23N5O2S/c1-13(2)16-12-28-21(27)26(16)18-9-10-22-20(25-18)24-14(3)17-11-23-19(29-17)15-7-5-4-6-8-15/h4-11,13-14,16H,12H2,1-3H3,(H,22,24,25)/t14?,16-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 811n/an/an/an/a7.525



Novartis AG

US Patent


Assay Description
The IDH1 (R132H) mutant catalyzes the reduced form of NADP+ (NADPH) and α-ketoglutarate (α-KG) to form nicotinamide adenine dinucleotide ph...


US Patent US8957068 (2015)


BindingDB Entry DOI: 10.7270/Q2TD9W28
More data for this
Ligand-Target Pair
Isocitrate dehydrogenase [NADP] cytoplasmic


(Homo sapiens (Human))
BDBM146320
PNG
(US8957068, 431 | US8957068, 432)
Show SMILES CC(C)[C@H]1COC(=O)N1c1ccnc(NC(C)c2cnc(s2)-c2ccccc2)n1 |r,w:15.16|
Show InChI InChI=1S/C21H23N5O2S/c1-13(2)16-12-28-21(27)26(16)18-9-10-22-20(25-18)24-14(3)17-11-23-19(29-17)15-7-5-4-6-8-15/h4-11,13-14,16H,12H2,1-3H3,(H,22,24,25)/t14?,16-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 40n/an/an/an/a7.425



Novartis AG

US Patent


Assay Description
Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a produc...


US Patent US8957068 (2015)


BindingDB Entry DOI: 10.7270/Q2TD9W28
More data for this
Ligand-Target Pair